Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

Phosphate-passivated SnO2 Electron Transport Layer for High Performance Perovskite Solar Cells.

Jiang E, Ai Y, Yan J, Li N, Lin L, Wang Z, Shou C, Yan B, Zeng Y, Sheng J, Ye J.

ACS Appl Mater Interfaces. 2019 Sep 17. doi: 10.1021/acsami.9b11817. [Epub ahead of print]

PMID:
31525907
2.

Adenoid cystic carcinoma of the gastroesophageal junction: A case report.

Shou CH, Li ZJ, Yang WL, Tjhoi WEH, Zhao ZC, Yu JR.

Medicine (Baltimore). 2019 Aug;98(35):e16999. doi: 10.1097/MD.0000000000016999.

3.

Topoisomerase inhibitors promote cancer cell motility via ROS-mediated activation of JAK2-STAT1-CXCL1 pathway.

Liu J, Qu L, Meng L, Shou C.

J Exp Clin Cancer Res. 2019 Aug 22;38(1):370. doi: 10.1186/s13046-019-1353-2.

4.

Multiple gastrointestinal stromal tumors: analysis of clinicopathologic characteristics and prognosis of 20 patients.

Li K, Tjhoi W, Shou C, Yang W, Zhang Q, Liu X, Yu J.

Cancer Manag Res. 2019 Jul 25;11:7031-7038. doi: 10.2147/CMAR.S197560. eCollection 2019.

5.

Mycoplasma hyorhinis infection promotes gastric cancer cell motility via β-catenin signaling.

Liu X, Rong Z, Shou C.

Cancer Med. 2019 Sep;8(11):5301-5312. doi: 10.1002/cam4.2357. Epub 2019 Jul 18.

6.

Relationship of prognostic nutritional index with prognosis of gastrointestinal stromal tumors.

Sun J, Mei Y, Zhu Q, Shou C, Tjhoi WEH, Yang W, Yu H, Zhang Q, Liu X, Yu J.

J Cancer. 2019 Jun 2;10(12):2679-2686. doi: 10.7150/jca.32299. eCollection 2019.

7.

[Mechanism of effective components of Mori Folium in alleviating insulin resistance based on JNK signaling pathway].

Liu YH, Mou X, Zhou DY, Shou CM.

Zhongguo Zhong Yao Za Zhi. 2019 Mar;44(5):1019-1025. doi: 10.19540/j.cnki.cjcmm.20181213.005. Chinese.

PMID:
30989864
8.

Value of fasting plasma glucose to screen gestational diabetes mellitus before the 24th gestational week in women with different pre-pregnancy body mass index.

Wei YM, Liu XY, Shou C, Liu XH, Meng WY, Wang ZL, Wang YF, Wang YQ, Cai ZY, Shang LX, Sun Y, Yang HX.

Chin Med J (Engl). 2019 Apr 20;132(8):883-888. doi: 10.1097/CM9.0000000000000158.

9.
10.

PRL-3 Promotes Ubiquitination and Degradation of AURKA and Colorectal Cancer Progression via Dephosphorylation of FZR1.

Zhang C, Qu L, Lian S, Meng L, Min L, Liu J, Song Q, Shen L, Shou C.

Cancer Res. 2019 Mar 1;79(5):928-940. doi: 10.1158/0008-5472.CAN-18-0520. Epub 2018 Nov 29.

PMID:
30498084
11.

Knockdown of PRL-3 increases mitochondrial superoxide anion production through transcriptional regulation of RAP1.

Yang Y, Lian S, Meng L, Tian Z, Feng Q, Wang Y, Wang P, Qu L, Shou C.

Cancer Manag Res. 2018 Oct 30;10:5071-5081. doi: 10.2147/CMAR.S165344. eCollection 2018.

12.

Clinical outcomes of imatinib dose escalation versus sunitinib in first-line imatinib-failure gastrointestinal stromal tumour.

Yang W, Li K, Yu J, Shou C, Zhang Q, Hong Y, Sun J, Yu H, Gao Y, Shen Q, Zhao Z, Zheng S.

Scand J Gastroenterol. 2018 Oct - Nov;53(10-11):1328-1334. doi: 10.1080/00365521.2018.1518484. Epub 2018 Oct 22.

PMID:
30346846
14.

Effects of transcutaneous acupoint electrical stimulation combined with low-dose sufentanil pretreatment on the incidence and severity of etomidate-induced myoclonus: A randomized controlled trial.

Lv Y, He H, Xie J, Jin W, Shou C, Pan Y, Wang L, Mo Y, Dai Q, Geng W, Wang J.

Medicine (Baltimore). 2018 Jun;97(23):e10969. doi: 10.1097/MD.0000000000010969.

15.

IGHG1 promotes motility likely through epithelial-mesenchymal transition in ovarian cancer.

Qian J, Ji F, Ye X, Cheng H, Ma R, Chang X, Shou C, Cui H.

Chin J Cancer Res. 2018 Apr;30(2):282-290. doi: 10.21147/j.issn.1000-9604.2018.02.11.

16.

Development of a novel albumin-based and maleimidopropionic acid-conjugated peptide with prolonged half-life and increased in vivo anti-tumor efficacy.

Feng J, Zhao C, Wang L, Qu L, Zhu H, Yang Z, An G, Tian H, Shou C.

Theranostics. 2018 Mar 7;8(8):2094-2106. doi: 10.7150/thno.22069. eCollection 2018.

17.

Extraction of flavonoids from Chrysanthemum morifolium and antitumor activity in vitro.

Liu YH, Mou X, Zhou DY, Zhou DY, Shou CM.

Exp Ther Med. 2018 Feb;15(2):1203-1210. doi: 10.3892/etm.2017.5574. Epub 2017 Nov 27.

18.

Sarsaparilla (Smilax Glabra Rhizome) Extract Activates Redox-Dependent ATM/ATR Pathway to Inhibit Cancer Cell Growth by S Phase Arrest, Apoptosis, and Autophagy.

She T, Feng J, Lian S, Li R, Zhao C, Song G, Luo J, Dawuti R, Cai S, Qu L, Shou C.

Nutr Cancer. 2017 Nov-Dec;69(8):1281-1289. doi: 10.1080/01635581.2017.1362447. Epub 2017 Nov 7.

PMID:
29111814
19.

PRL-3 promotes telomere deprotection and chromosomal instability.

Lian S, Meng L, Yang Y, Ma T, Xing X, Feng Q, Song Q, Liu C, Tian Z, Qu L, Shou C.

Nucleic Acids Res. 2017 Jun 20;45(11):6546-6571. doi: 10.1093/nar/gkx392.

20.

Gene regulatory pattern analysis reveals essential role of core transcriptional factors' activation in triple-negative breast cancer.

Min L, Zhang C, Qu L, Huang J, Jiang L, Liu J, Pinello L, Yuan GC, Shou C.

Oncotarget. 2017 Mar 28;8(13):21938-21953. doi: 10.18632/oncotarget.15749.

21.

Repressor activator protein 1-promoted colorectal cell migration is associated with the regulation of Vimentin.

Yang Y, Ye C, Wang L, An G, Tian Z, Meng L, Qu L, Lian S, Shou C.

Tumour Biol. 2017 Apr;39(4):1010428317695034. doi: 10.1177/1010428317695034.

PMID:
28381157
22.

125I-F56 Peptide as Radioanalysis Agent Targeting VEGFR1 in Mice Xenografted with Human Gastric Tumor.

Zhu H, Zhao C, Liu F, Wang L, Feng J, Shou C, Yang Z.

ACS Med Chem Lett. 2017 Jan 20;8(2):266-269. doi: 10.1021/acsmedchemlett.6b00498. eCollection 2017 Feb 9.

23.

A randomized clinical trial of exercise during pregnancy to prevent gestational diabetes mellitus and improve pregnancy outcome in overweight and obese pregnant women.

Wang C, Wei Y, Zhang X, Zhang Y, Xu Q, Sun Y, Su S, Zhang L, Liu C, Feng Y, Shou C, Guelfi KJ, Newnham JP, Yang H.

Am J Obstet Gynecol. 2017 Apr;216(4):340-351. doi: 10.1016/j.ajog.2017.01.037. Epub 2017 Feb 1.

PMID:
28161306
24.

Antibody Array Revealed PRL-3 Affects Protein Phosphorylation and Cytokine Secretion.

Yang Y, Lian S, Meng L, Qu L, Shou C.

PLoS One. 2017 Jan 9;12(1):e0169665. doi: 10.1371/journal.pone.0169665. eCollection 2017.

25.

Integrated analysis identified an intestinal-like and a diffuse-like gene sets that predict gastric cancer outcome.

Zhang C, Min L, Liu J, Tian W, Han Y, Qu L, Shou C.

Tumour Biol. 2016 Nov 17. [Epub ahead of print]

PMID:
27858295
26.

Role and Characterization of Synuclein-γ Unconventional Protein Secretion in Cancer Cells.

Liu C, Qu L, Shou C.

Methods Mol Biol. 2016;1459:215-27. doi: 10.1007/978-1-4939-3804-9_15.

PMID:
27665562
27.

Effect of Regular Exercise Commenced in Early Pregnancy on the Incidence of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Randomized Controlled Trial.

Wang C, Wei Y, Zhang X, Zhang Y, Xu Q, Su S, Zhang L, Liu C, Feng Y, Shou C, Guelfi KJ, Newnham JP, Yang H.

Diabetes Care. 2016 Oct;39(10):e163-4. doi: 10.2337/dc16-1320. No abstract available.

PMID:
27660125
28.

Different Risk Indictors of Diabetic Nephropathy in Transforming Growth Factor-beta1 T869C CC/CT Genotype and TT Genotype.

Mou X, Liu Y, Zhou D, Hu Y, Ma G, Shou C, Chen J, Zhou D.

Iran J Public Health. 2016 Jun;45(6):761-7.

29.

Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients.

Min L, Zhang C, Ma R, Li X, Yuan H, Li Y, Chen R, Liu C, Guo J, Qu L, Shou C.

BMC Cancer. 2016 Sep 5;16:717. doi: 10.1186/s12885-016-2750-y.

30.

PRL-3 promotes cell adhesion by interacting with JAM2 in colon cancer.

Lian S, Meng L, Xing X, Yang Y, Qu L, Shou C.

Oncol Lett. 2016 Sep;12(3):1661-1666. Epub 2016 Jul 11.

31.

Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer.

Liu C, Shi B, Hao C, Wang Q, Lv Q, Xing N, Shou J, Qu L, Gao Y, Qin C, Zhao J, Shou C.

Oncotarget. 2016 Jul 12;7(28):43432-43441. doi: 10.18632/oncotarget.9468.

32.

Expression of γ-Synuclein in Bladder Carcinoma: A Possible Marker for Prognosis.

Chen Z, Ji Z, Wang Q, Shi B, Shou C, Liu C, Fan H, Li H, Davidson KT, Wakefield MR, Ball TW, Fang Y.

Anticancer Res. 2016 Mar;36(3):951-6. Erratum in: Anticancer Res. 2016 Apr;36(4):2041.

PMID:
26976983
33.

Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials.

Mou X, Zhou DY, Zhou DY, Ma JR, Liu YH, Chen HP, Hu YB, Shou CM, Chen JW, Liu WH, Ma GL.

PLoS One. 2016 Feb 22;11(2):e0149513. doi: 10.1371/journal.pone.0149513. eCollection 2016. Review.

34.

Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition.

Huang D, Duan H, Huang H, Tong X, Han Y, Ru G, Qu L, Shou C, Zhao Z.

Sci Rep. 2016 Feb 5;6:20502. doi: 10.1038/srep20502.

35.

In Situ Hybridization of Breast Cancer Markers.

Min L, Shou C.

Methods Mol Biol. 2016;1406:53-9. doi: 10.1007/978-1-4939-3444-7_4.

PMID:
26820944
36.

N-Terminal Polypeptide of Annexin A2 Decreases Infection of Mycoplasma hyorhinis to Gastric Cancer Cells.

Yuan S, Qu L, Shou C.

PLoS One. 2016 Jan 26;11(1):e0147776. doi: 10.1371/journal.pone.0147776. eCollection 2016. Erratum in: PLoS One. 2016;11(4):e0153995.

37.

Radiolabeling and evaluation of (64)Cu-DOTA-F56 peptide targeting vascular endothelial growth factor receptor 1 in the molecular imaging of gastric cancer.

Zhu H, Zhao C, Liu F, Wang L, Feng J, Zhou Z, Qu L, Shou C, Yang Z.

Am J Cancer Res. 2015 Oct 15;5(11):3301-10. eCollection 2015.

38.

A VEGFR1 antagonistic peptide inhibits tumor growth and metastasis through VEGFR1-PI3K-AKT signaling pathway inhibition.

Zhou Z, Zhao C, Wang L, Cao X, Li J, Huang R, Lao Q, Yu H, Li Y, Du H, Qu L, Shou C.

Am J Cancer Res. 2015 Sep 15;5(10):3149-61. eCollection 2015.

39.

PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.

Zhang C, Tian W, Meng L, Qu L, Shou C.

J Mol Med (Berl). 2016 Apr;94(4):401-15. doi: 10.1007/s00109-015-1350-7. Epub 2015 Nov 9.

PMID:
26548949
40.

HNRNPC as a candidate biomarker for chemoresistance in gastric cancer.

Huang H, Han Y, Zhang C, Wu J, Feng J, Qu L, Shou C.

Tumour Biol. 2016 Mar;37(3):3527-34. doi: 10.1007/s13277-015-4144-1. Epub 2015 Oct 9.

PMID:
26453116
41.

Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer.

Zhang C, Min L, Zhang L, Ma Y, Yang Y, Shou C.

Tumour Biol. 2016 Feb;37(2):2193-207. doi: 10.1007/s13277-015-3938-5. Epub 2015 Sep 9.

PMID:
26349752
42.

Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesis.

Zhao C, Su Y, Zhang J, Feng Q, Qu L, Wang L, Liu C, Jiang B, Meng L, Shou C.

Cancer Sci. 2015 Nov;106(11):1596-606. doi: 10.1111/cas.12797. Epub 2015 Oct 16.

43.

Prognostic value and characterization of the ovarian cancer-specific antigen CA166-9.

Ji F, Chang X, Liu C, Meng L, Qu L, Wu J, Liu C, Cui H, Shou C.

Int J Oncol. 2015 Oct;47(4):1405-15. doi: 10.3892/ijo.2015.3115. Epub 2015 Aug 6.

PMID:
26251984
44.

Daucosterol inhibits cancer cell proliferation by inducing autophagy through reactive oxygen species-dependent manner.

Zhao C, She T, Wang L, Su Y, Qu L, Gao Y, Xu S, Cai S, Shou C.

Life Sci. 2015 Sep 15;137:37-43. doi: 10.1016/j.lfs.2015.07.019. Epub 2015 Jul 22.

PMID:
26209138
45.

Synuclein-γ promotes migration of MCF7 breast cancer cells by activating extracellular-signal regulated kinase pathway and breaking cell-cell junctions.

Zhuang Q, Liu C, Qu L, Shou C.

Mol Med Rep. 2015 Sep;12(3):3795-3800. doi: 10.3892/mmr.2015.3799. Epub 2015 May 19.

PMID:
25997706
46.

Prognostic characteristics of duodenal gastrointestinal stromal tumours.

Zhang Q, Shou CH, Yu JR, Yang WL, Liu XS, Yu H, Gao Y, Shen QY, Zhao ZC.

Br J Surg. 2015 Jul;102(8):959-64. doi: 10.1002/bjs.9831. Epub 2015 May 18.

47.

[Numerical assessment of impeller features of centrifugal blood pump based on fast hemolysis approximation model].

Shou C, Guo Y, Su L, Li Y.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2014 Dec;31(6):1260-4. Chinese.

PMID:
25868241
48.

Combined expression of metastasis related markers Naa10p, SNCG and PRL-3 and its prognostic value in breast cancer patients.

Min L, Ma RL, Yuan H, Liu CY, Dong B, Zhang C, Zeng Y, Wang L, Guo JP, Qu LK, Shou CC.

Asian Pac J Cancer Prev. 2015;16(7):2819-26.

49.

Cancer and embryo expression protein 65 promotes cancer cell growth and metastasis.

Jin G, Peng L, Zhang J, Qu L, Shou C.

Oncol Lett. 2015 Apr;9(4):1772-1778. Epub 2015 Feb 12.

50.

[Preparation and identification of monoclonal antibody against repression and activation protein 1].

Meng L, Shou C, Lian S.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Mar;31(3):397-401. Chinese.

PMID:
25744847

Supplemental Content

Support Center